Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy

  • Yuriy V. Shebzukhov
  • , Ekaterina P. Koroleva
  • , Svetlana V. Khlgatian
  • , Maria A. Lagarkova
  • , Andrey A. Meshcheryakov
  • , Mikhail R. Lichinitser
  • , Julia Karbach
  • , Elke Jager
  • , Dmitry V. Kuprash
  • , Sergei A. Nedospasov

Producción científica: Articlerevisión exhaustiva

Resumen

Thymidylate synthase (TYMS), the critical enzyme for DNA synthesis and a target for chemotherapy, was recently characterized as an oncogene and a potential target for specific immunotherapy. Here we report TYMS-specific antibody response in a fraction of colon cancer patients. Humoral immune response to TYMS is induced by chemotherapy using TYMS inhibitors, such as 5-fluorouracil (5-FU), and may be associated with tumor burden. Therefore, TYMS may serve as a useful serological biomarker for monitoring the course of disease and treatment in cancer patients.

Idioma originalEnglish (US)
Páginas (desde-hasta)88-93
Número de páginas6
PublicaciónImmunology Letters
Volumen100
N.º1
DOI
EstadoPublished - ago 15 2005
Publicado de forma externa

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Huella

Profundice en los temas de investigación de 'Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy'. En conjunto forman una huella única.

Citar esto